Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)

By sjmartinez • July 2, 2024

Nikitas J, Lam E, Booker KA, Fendler WP, Eiber M, Hadaschik B, Herrmann K, Hirmas N, Lanzafame H, Stuschke M, Czernin J, Steinberg ML, Nickols NG, Kishan AU, Calais J. Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial). J Nucl Med. 2024 Jul 1;65(7):1076-1079. doi: 10.2967/jnumed.123.267004. PMID: 38664019.

Tags: PET, prostate cancer, prostate-specific membrane antigen, Publications, Pulmonary, Critical Care & Sleep Medicine, Radiation therapy, Randomized clinical trial

Systems genetics uncovers associations among host amylase locus, gut microbiome, and metabolic traits in mice

Zhang Q, Hutchison ER, Pan C, Warren MF, Keller MP, Attie AD, Lusis AJ, Rey FE. Systems genetics uncovers associations among host amylase locus, gut[...]

Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism Improve Outcomes? Insights from a Meta-analysis

Maqsood MH, Zhang RS, Rosenfeld K, Moriarty JM, Rosovsky RP, Horowitz JM, Alviar CL, Bangalore S. Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism[...]

Relieve the suffering: palliative care for the next decade

Rosa WE, Connor S, Aggarwal G, Alsirafy S, Brennan J, Davies H, Downing J, Ferrell B, Harding R, Knaul FM, Luyirika EBK, Marroquín MM, Marston[...]